Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PMCB — PharmaCyte Biotech, Inc.

CIK 1214717 BOSTON, MA
Back to PMCB Full portfolio

Position in PMCB

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$95,669
-$34,522 QoQ
Shares Held
124,247
-36.5% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 30 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMCB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. PMCB ranks #446 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PMCB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $95,669 124,247
2026-03-31 $130,191 195,660
2025-12-31 $89,662 123,844
2025-09-30 $122,754 126,603
2025-06-30 $137,996 126,603
2025-03-31 $173,668 138,935
2024-12-31 $258,634 164,736
2024-09-30 $321,261 168,200
2024-06-30 $346,145 176,605
2024-03-31 $474,665 200,281
2023-12-31 $465,775 215,637
2023-09-30 $460,131 219,110
2023-06-30 $626,551 219,074
2023-03-31 $510,018 175,264
2022-12-31 $513,523 175,264
2022-09-30 $421,456 175,607
2022-06-30 $393,359 175,607
2022-03-31 $394,502 171,523
2021-12-31 $208,937 83,575
2021-09-30 $147,753 46,610